SPBC800.10c Antibody

Shipped with Ice Packs
In Stock

Description

Antibody Structure and Function

Antibodies are Y-shaped proteins composed of two heavy chains and two light chains, with variable domains (Fab) mediating antigen binding and constant domains (Fc) facilitating immune system interactions . Their primary functions include neutralizing pathogens, facilitating phagocytosis, and recruiting immune effector cells. SPBC800.10c, like other antibodies, would likely target a specific antigen, such as a viral protein or tumor marker, via its paratope (binding site).

Antibody Engineering Strategies

Modern antibody engineering often employs computational platforms to optimize binding affinity and epitope targeting, as demonstrated in SARS-CoV-2 neutralizing antibodies . For example, the CR3022 antibody targets a non-ACE2-binding epitope on the viral spike protein, enabling combination therapies to prevent resistance . If SPBC800.10c follows similar approaches, its design might prioritize cross-reactivity or multi-specificity to broaden therapeutic applications.

Neutralization Mechanisms

Antibodies neutralize pathogens by blocking critical interactions, such as viral entry or enzymatic activity. For instance, the WRAIR-2125 antibody neutralizes all major SARS-CoV-2 variants by targeting a conserved epitope on the receptor-binding domain (RBD) . SPBC800.10c’s mechanism would depend on its antigen target, but successful neutralization typically requires high-affinity binding and epitope conservation across variants.

Therapeutic Potential

Experimental monoclonal antibodies, such as those targeting Epstein-Barr virus (EBV) glycoproteins gH/gL, have shown promise in preclinical studies by blocking viral fusion and providing prophylactic protection . If SPBC800.10c targets a similar viral or oncogenic antigen, its efficacy would depend on in vivo stability, half-life extension, and lack of immunogenicity. The inclusion of Fc modifications (e.g., NNAS mutations) could enhance therapeutic profiles .

Research Challenges

Antibody resistance and viral escape mutations pose significant hurdles, as observed with SARS-CoV-2 spike variants . Effective antibodies often require epitope redundancy or multi-specific binding to mitigate resistance. For SPBC800.10c, robust epitope characterization and combination therapies would be critical to ensuring long-term efficacy.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPBC800.10cUncharacterized calcium-binding protein C800.10c antibody
Target Names
SPBC800.10c
Uniprot No.

Target Background

Database Links
Subcellular Location
Cytoplasm, cytoskeleton.

Q&A

What is SPBC800.10c and what cellular processes is it involved in?

SPBC800.10c is a protein found in Schizosaccharomyces pombe (fission yeast), with UniProt accession number Q9HGL2. While specific detailed functions are still being characterized, it appears to be related to chromatin regulation pathways in S. pombe. Chromatin regulators in S. pombe, such as Abo1 and HIRA, have been identified as regulators of various cellular processes including nitrogen-starvation induced quiescence . The SPBC800.10c protein likely functions within this broader context of chromatin regulation, potentially influencing gene expression, DNA replication, or DNA repair mechanisms. Understanding its exact role requires experimental validation using techniques such as chromatin immunoprecipitation (ChIP), gene knockout studies, and protein-protein interaction analyses.

What are the validated applications for the SPBC800.10c antibody?

The SPBC800.10c antibody has been validated for specific research applications including:

  • Enzyme-Linked Immunosorbent Assay (ELISA) - For quantitative detection of the SPBC800.10c protein in sample preparations

  • Western Blotting (WB) - For identification of the SPBC800.10c protein in cell or tissue lysates

When using these applications, researchers should follow standardized protocols for immunodetection techniques. For Western blotting, typical procedures involve sample preparation with appropriate lysis buffers, protein denaturation with SDS sample buffer, gel electrophoresis, transfer to PVDF membranes, blocking, and incubation with the primary SPBC800.10c antibody followed by detection with an appropriate secondary antibody system .

What are the optimal storage and handling conditions for the SPBC800.10c antibody?

The SPBC800.10c antibody should be stored at -20°C or -80°C upon receipt. Researchers should avoid repeated freeze-thaw cycles to maintain antibody integrity and activity. The antibody is supplied in liquid form with a storage buffer containing 50% glycerol, 0.01M PBS at pH 7.4, and 0.03% Proclin 300 as a preservative .

For long-term storage, aliquoting the antibody into smaller volumes is recommended to minimize freeze-thaw cycles. When handling the antibody, use sterile techniques and keep on ice when in use. For optimal performance in experimental applications, always follow the manufacturer's recommendations for antibody dilutions and incubation conditions.

How should I optimize antibody dilutions for Western blotting experiments?

When optimizing the SPBC800.10c antibody for Western blotting, a systematic approach to dilution testing is essential. Begin with a range of antibody dilutions (typically 1:500 to 1:5000) to determine the optimal concentration that provides the best signal-to-noise ratio.

Optimization protocol:

  • Prepare identical Western blot membranes with your samples and positive controls

  • Block all membranes using the same blocking solution (typically 5% non-fat dry milk or BSA in TBST)

  • Incubate separate membranes with different dilutions of the SPBC800.10c antibody

  • Process all membranes identically for secondary antibody incubation and detection

  • Compare results to identify the dilution that provides specific binding with minimal background

Additionally, optimize exposure times during detection to avoid oversaturation of signals. The optimal antibody dilution may vary depending on sample type, protein abundance, and detection method used (chemiluminescence, fluorescence, etc.) .

What controls should I include when using the SPBC800.10c antibody in my experiments?

Proper experimental controls are crucial for reliable interpretation of results when using the SPBC800.10c antibody:

Essential controls include:

  • Positive control: Lysate from wild-type S. pombe (strain 972/ATCC 24843) expressing normal levels of SPBC800.10c protein

  • Negative control: Lysate from S. pombe with SPBC800.10c deletion or knockdown, if available

  • Secondary antibody-only control: Samples processed without primary antibody to assess non-specific binding of the secondary antibody

  • Loading control: Detection of a housekeeping protein (e.g., actin or tubulin) to ensure equal loading across samples

  • Peptide competition assay: Pre-incubation of the antibody with excess purified SPBC800.10c protein or peptide to confirm antibody specificity

These controls help distinguish specific signals from background noise and validate the authenticity of observed results. Document all control results alongside experimental data for comprehensive interpretation and troubleshooting.

How can I use the SPBC800.10c antibody in chromatin immunoprecipitation (ChIP) experiments?

While ChIP is not explicitly listed among the validated applications for this antibody, researchers interested in exploring SPBC800.10c's interactions with chromatin could adapt standard ChIP protocols:

  • Cross-linking: Treat S. pombe cells with 1% formaldehyde for 10-15 minutes to cross-link protein-DNA interactions

  • Cell lysis and sonication: Lyse cells and sonicate to shear chromatin to fragments of approximately 200-500 bp

  • Pre-clearing: Incubate chromatin with protein A/G beads and non-immune serum to reduce non-specific binding

  • Immunoprecipitation: Incubate pre-cleared chromatin with the SPBC800.10c antibody (typically 2-5 μg per immunoprecipitation) overnight at 4°C

  • Washing and elution: Collect antibody-protein-DNA complexes using protein A/G beads, wash extensively, and elute

  • Reverse cross-linking: Incubate samples at 65°C overnight to reverse formaldehyde cross-links

  • DNA purification: Extract and purify DNA for subsequent analysis by qPCR or sequencing

If adapting this antibody for ChIP applications, thorough validation is necessary, including ChIP-qPCR of known targets or regions where SPBC800.10c is expected to bind.

What sample preparation methods are recommended for detecting SPBC800.10c in S. pombe lysates?

Effective sample preparation is critical for successful detection of SPBC800.10c:

  • Cell harvesting: Collect cells during the appropriate growth phase, considering that protein expression may vary with cell cycle or environmental conditions

  • Lysis method selection:

    • For Western blotting: Use a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, and protease inhibitor cocktail

    • For ELISA: Use milder lysis conditions that maintain native protein structure

  • Mechanical disruption: S. pombe has a tough cell wall; use glass beads and vortexing or a cell disruptor for efficient lysis

  • Clearing lysates: Centrifuge at 12,000-15,000g for 10-15 minutes at 4°C to remove cell debris

  • Protein quantification: Perform Bradford or BCA assay to standardize protein concentrations

  • Sample preparation: For Western blotting, mix samples with SDS sample buffer and heat at 100°C for 5 minutes

Prepare fresh lysates whenever possible, and if storage is necessary, add glycerol to a final concentration of 10-20% and store at -80°C to preserve protein integrity.

How can I determine if SPBC800.10c has a role in nitrogen-starvation induced quiescence similar to other chromatin regulators in S. pombe?

Investigating SPBC800.10c's potential role in nitrogen-starvation induced quiescence requires a comparative approach with known regulators like HIRA:

  • Growth condition experiments:

    • Culture wild-type and SPBC800.10c-deficient S. pombe strains in nitrogen-rich and nitrogen-depleted media

    • Monitor viability, cellular morphology, and quiescence entry/exit dynamics

  • Chromatin state analysis:

    • Perform ChIP-seq using the SPBC800.10c antibody under normal and nitrogen-starved conditions

    • Compare binding profiles with those of known quiescence regulators like HIRA

  • Transcriptome analysis:

    • Conduct RNA-seq comparing wild-type and SPBC800.10c-deficient strains during nitrogen starvation

    • Identify differentially expressed genes and compare with known quiescence-related gene signatures

  • Genetic interaction studies:

    • Create double mutants lacking both SPBC800.10c and known quiescence regulators (e.g., HIRA)

    • Assess synthetic phenotypes that may indicate pathway relationships

Analysis should focus on identifying genes or chromatin regions that show differential regulation dependent on SPBC800.10c during nitrogen starvation, potentially indicating a role in quiescence regulation.

What approaches can I use to characterize post-translational modifications of SPBC800.10c?

Characterizing post-translational modifications (PTMs) of SPBC800.10c requires specialized techniques:

  • Immunoprecipitation and mass spectrometry workflow:

    • Immunoprecipitate SPBC800.10c using the antibody from S. pombe lysates

    • Separate proteins by SDS-PAGE and excise the band corresponding to SPBC800.10c

    • Perform in-gel digestion with trypsin or other proteases

    • Analyze peptides by liquid chromatography-tandem mass spectrometry (LC-MS/MS)

    • Search for common PTMs such as phosphorylation, acetylation, methylation, SUMOylation, or ubiquitination

  • PTM-specific detection methods:

    • Use phospho-specific stains (e.g., Pro-Q Diamond) to detect phosphorylation

    • Employ PTM-specific antibodies in Western blots after immunoprecipitation with SPBC800.10c antibody

    • Use ELISA to quantify specific PTMs on immunoprecipitated SPBC800.10c

  • Functional validation:

    • Create S. pombe strains with mutations at PTM sites (e.g., S to A for phosphorylation sites)

    • Compare phenotypes of mutant strains with wild-type to assess functional significance of PTMs

Correlation of PTM patterns with cellular conditions or stress responses may provide insights into regulation mechanisms of SPBC800.10c function.

How can I investigate potential protein-protein interactions of SPBC800.10c?

Understanding SPBC800.10c's protein interaction network can provide valuable insights into its function:

  • Co-immunoprecipitation (Co-IP):

    • Lyse S. pombe cells under non-denaturing conditions

    • Immunoprecipitate SPBC800.10c using the antibody

    • Analyze co-precipitated proteins by mass spectrometry or Western blotting with antibodies against suspected interaction partners

    • Validate interactions with reciprocal Co-IP experiments

  • Proximity-based labeling:

    • Create fusion proteins of SPBC800.10c with BioID or APEX2

    • Express in S. pombe and activate the labeling enzyme

    • Purify biotinylated proteins and identify by mass spectrometry

  • Yeast two-hybrid screening:

    • Use SPBC800.10c as bait against an S. pombe cDNA library

    • Identify potential interactors through selection on appropriate media

    • Confirm interactions with Co-IP or pull-down assays using the SPBC800.10c antibody

Document interaction conditions carefully, as some interactions may be transient, cell cycle-dependent, or occur only under specific stress conditions.

What are common pitfalls when using polyclonal antibodies like SPBC800.10c antibody and how can I address them?

Polyclonal antibodies present specific challenges that require careful experimental design:

ChallengeCauseSolution
Batch-to-batch variabilityDifferent immunized animals produce different antibody mixturesPurchase sufficient quantity from single batch for long-term projects; validate each new batch
Cross-reactivityAntibodies recognizing epitopes present on multiple proteinsPerform peptide competition assays; validate specificity with knockout controls
Variable sensitivityDifferent epitopes recognized with different affinitiesOptimize antibody concentration for each application; consider enriching target protein when possible
Background noiseNon-specific binding to sample componentsUse more stringent washing steps; optimize blocking conditions; try different blocking agents
False positivesRecognition of similar epitopes on other proteinsConfirm results with alternative detection methods or second antibody against different epitope

When interpreting results, always consider these potential limitations and include appropriate controls to distinguish genuine signals from artifacts .

How do I interpret inconsistent results between ELISA and Western blot when using the SPBC800.10c antibody?

Discrepancies between ELISA and Western blot results are common and may reflect biological or methodological differences:

Possible causes and interpretations:

  • Epitope accessibility:

    • ELISA often uses native protein conformations while Western blot uses denatured proteins

    • Different epitopes may be accessible in each method

    • Solution: Try native PAGE Western blot to maintain protein folding

  • Sensitivity differences:

    • ELISA typically has higher sensitivity than Western blot

    • Low abundance proteins may be detectable by ELISA but not Western blot

    • Solution: Enrich target protein by immunoprecipitation before Western blot

  • Cross-reactivity profiles:

    • ELISA may detect cross-reactive proteins that run at different molecular weights in Western blot

    • Solution: Use peptide competition assays in both techniques to confirm specificity

  • Post-translational modifications:

    • Different PTMs may affect antibody recognition differently in each technique

    • Solution: Use phosphatase or other enzyme treatments to remove PTMs before analysis

When reporting such discrepancies, document the experimental conditions thoroughly and consider them as complementary rather than contradictory results that may reveal important biological insights about protein structure or modifications .

How can I quantitatively analyze Western blot data using the SPBC800.10c antibody?

Rigorous quantification of Western blot data requires systematic approaches:

  • Image acquisition:

    • Use a digital imaging system with a linear dynamic range

    • Avoid saturated signals that prevent accurate quantification

    • Capture multiple exposures to ensure signals fall within the linear range

  • Densitometry analysis:

    • Use software like ImageJ, ImageLab, or similar platforms

    • Define regions of interest consistently across all lanes

    • Subtract background using a rolling ball algorithm or nearby blank areas

    • Normalize target protein signals to loading control (e.g., actin, tubulin)

  • Statistical analysis:

    • Run at least three biological replicates for statistical validity

    • Apply appropriate statistical tests (t-test, ANOVA) based on experimental design

    • Report both mean values and measures of variance (standard deviation or standard error)

  • Validation approaches:

    • Create a standard curve using purified recombinant SPBC800.10c protein

    • Include positive controls of known concentration in each experiment

    • Verify linearity of signal across the range of protein amounts analyzed

Present quantitative Western blot data in bar graphs with error bars, accompanied by representative blot images showing all experimental conditions and controls .

How might the SPBC800.10c antibody be used to study chromatin dynamics during DNA damage response in S. pombe?

The SPBC800.10c antibody could be instrumental in investigating chromatin reorganization during DNA damage:

  • ChIP-seq time course analysis:

    • Induce DNA damage in S. pombe using agents like methyl methanosulfonate (MMS)

    • Perform ChIP-seq with the SPBC800.10c antibody at multiple time points after damage

    • Map dynamic changes in SPBC800.10c binding across the genome during repair

    • Correlate with known DNA damage response elements and repair factors

  • Co-localization studies:

    • Combine ChIP with the SPBC800.10c antibody with ChIP for known DNA repair factors

    • Identify regions of co-occupancy that may represent repair complexes

    • Validate protein interactions with Co-IP under damage conditions

  • Chromatin accessibility analysis:

    • Compare chromatin accessibility (using ATAC-seq or MNase-seq) between wild-type and SPBC800.10c-deficient strains after DNA damage

    • Identify regions where SPBC800.10c may influence nucleosome positioning during repair

  • Functional rescue experiments:

    • In SPBC800.10c-deficient strains with DNA damage phenotypes, express specific domains of the protein

    • Use the antibody to confirm expression and localization of truncated proteins

    • Determine which domains are necessary and sufficient for DNA damage response functions

This research could reveal previously unknown roles of SPBC800.10c in genome maintenance and stress response pathways.

Can the SPBC800.10c antibody be adapted for super-resolution microscopy to study nuclear localization patterns?

Adapting the SPBC800.10c antibody for super-resolution microscopy requires specific optimization steps:

  • Antibody labeling strategies:

    • Direct labeling: Conjugate fluorophores (Alexa Fluor 647, Cy5) directly to the SPBC800.10c antibody

    • Indirect detection: Use fluorescently-labeled secondary antibodies with appropriate spectral properties

    • For STORM/PALM: Consider photoconvertible fluorophore conjugation

  • Sample preparation optimization:

    • Test multiple fixation methods (formaldehyde, methanol) to preserve epitope accessibility

    • Optimize permeabilization to ensure antibody penetration while maintaining nuclear structure

    • Reduce background fluorescence through careful blocking and washing steps

  • Imaging validation:

    • Confirm specificity using SPBC800.10c-deficient strains as negative controls

    • Compare patterns with other nuclear markers to validate subnuclear localization

    • Perform dual-color imaging with known interaction partners to assess co-localization at nanoscale resolution

  • Quantitative analysis:

    • Develop analysis workflows to quantify clustering, distance distributions, or co-localization

    • Compare patterns under different physiological conditions or cell cycle stages

This approach could reveal previously undetectable subnuclear organization patterns of SPBC800.10c and its relationship to chromatin domains or nuclear bodies .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.